dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Pöördumine

Sotsiaalministeerium · 3. jaanuar 2020
Viit
1.5-1.1/13-1
Registreeritud
3. jaanuar 2020
Dokumendi liik
Sissetulev kiri
Adressaat
Phoenix Group
Saabumis/saatmisviis
DVK
Funktsioon
1.5 Asjaajamine. Info- ja kommunikatsioonitehnoloogia arendus ja haldus
Sari
1.5-1.1 Teabenõuded, märgukirjad, selgitustaotlused
Toimik
1.5-1.1/2020
Vastutaja
Katri Eespere (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Terviseala asekantsleri vastutusvaldkond)
Lahendamise tähtaeg
2. veebruar 2020

Failid

  • 📎19-01399-2.pdf1 KB
  • 📎19-01399.pdf70 KB

Sisu (failidest)

Resolutsiooni liik: Riigikantselei resolutsioon Viide: Phoenix Pharmahandel GmbH &Co KG / 01.10.2019 / ; Riigikantselei / 09.10.2019 / 7-15 /19-01399 Resolutsiooni teema: Pöördumise edastamine Adressaat: Sotsiaalministeerium Ülesanne: Edastame peaministrile saadetud kirja. Tähtaeg: Kontroll: Johannes Merilai Kinnitaja: Maimu Mesi, Peaministri büroo referent Kinnitamise kuupäev: 03.01.2020 Resolutsiooni koostaja: Maimu Mesi [email protected], 693 5703 ‘wuziuu sxIgi1cantseeisse 7” a 09. 10, 2919 PHOENIX SE- Pfinqsw€,d,ra6. 0-i 2 - 55199 Varnhein Stefan Herfeld Executive Board Member Mr. JUn Ratas Prime Minister of Estonia PHOENIX Pharma SE Stenbock House Rahukohtu 3 PfingstweidstraRe 10-12 - 68199 Mannheim, Germany 10130 Tallinn Phone +49 621 8505—251 Estonia Fax +49 621 8505—200 251 s. [email protected] October 1, 2019 Subject: Changes in pharmacy retail market legislation entering into force on 1 April 2020 Dear Prime Minister, With this letter the PHOENIX group would like to address the serious concern related to major changes in Estonian law affecting whole pharmacy retail market and to protection of significant investments of Germany headquartered PHOENIX group in the Republic of Estonia. PHOENIX group is a leading pharmaceutical trader in Europe. In pharmaceutical wholesale PHOENIX group is active in 26 European countries supplying pharmacies and medical institutions with medicines and other health products. In pharmacy retail PHOENIX group operates more than 2,500 pharmacies in 14 countries most of them operate under the corporate brand RENU. — We entered the Estonian market after acquisition of Finnish Tamro group in 2001. During the years of activity in Estonia we have developed pharmaceutical wholesale activity and invested into and built up an operation of more than 80 BENU pharmacies. Today, PHOENIX group through BENU Apteek Eesti OU is one of the major service providers to the Estonian people. With the great concern we have observed the changes in Estonian legislation regarding pharmaceutical sector. In 2014 and 2015 amendments were adopted to the Estonian Medicinal Products Act stipulating that wholesalers of medicinal products are prohibited from having holdings in general pharmacies, or having any other dominant influence over holdings that have activity licence of a general pharmacy. In addition, a requirement was established that a pharmacist must hold more than 50% of the shares of the pharmacy company. PHOENIX Pharma SE Pfingstweidstral0e ‘0—12 Executive Board: Registered Office: Mannheim 68199 Mannheim Helmut Fischer Local Court Mannheim 119.4 727494 Germany Frank GrolSe-Natrop VAT Req No. DE 311 309 783 Address: Scefan Herfeld 68197 Mannheim Creditor Identifier: Germany DE7SZZZ00002OI 7868 Phone +49 621 8505—0 PHOENIX The above—mentioned amendments have a significant impact on the activities of the PHOENIX group in Estonia and endangers the availability of medicines in Estonia. As a consequence of the amendments to the Medicinal Products Act, PHOENIX group must divest its holdings in the pharmacies operating in Estonia by 1 April 2020 at the latest or wind up their activities. However, the amendments to the Medicinal Products Act do not prescribe any compensation for compulsory dissolution of the operation of general pharmacies belonging to wholesalers. As far as the PHOENIX group is aware, no realistic steps have been taken to solve the specified problem by drafting an Act covering the compensation package to investors deriving from expropriation. Furthermore, no analysis have been made to specify how the availability of medicines is affected by — the law amendments and guaranteed after 1 April 2020. It should be noted that enforcement of the law amendments may lead to closing almost 300 pharmacies in Estonia as of 1 April 2020. The planned execution of the changes in the pharmacy sector is in the clear contradiction with the reputation of Estonia as a modern and reliable investment environment that is well known in Europe and in Germany, in particular. I kindly ask and appreciate if you would find an opportunity to personally meet with me in the near future in Estonia to discuss this topic. Thank you very much for the consideration you will give to this request and I remain at your disposal should you need any further information or propose time for the meeting (contact person in Estonia: Mr. Leon Jankelevitsh, Managing Director Tamro Baltics, e—mail [email protected], phone +37256 220 133). Si of the Executive Board Retail Page 2 of 2
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel